John L. Knopf
No más puestos en curso
Historial de carrera de John L. Knopf
Antiguos cargos conocidos de John L. Knopf.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ACCELERON PHARMA INC. | Director/Miembro de la Junta | 01/06/2003 | 01/12/2016 |
| Director Ejecutivo | 01/06/2003 | 01/12/2016 | |
| Fundador | 01/06/2003 | 01/12/2016 | |
| Presidente | 01/06/2003 | 01/12/2016 | |
Wyeth Research
 Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The company is based in Cambridge, MA. | Corporate Officer/Principal | - | - |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Director Técnico/Científico/I+D | 01/01/1982 | - |
Formación de John L. Knopf.
| State University of New York at Buffalo | Doctorate Degree |
| Stony Brook University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Wyeth Research
Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The company is based in Cambridge, MA. | Commercial Services |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- John L. Knopf
- Experiencia